HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Heterozygous mutation in 5'-untranslated region of sepiapterin reductase gene (SPR) in a patient with dopa-responsive dystonia.

Abstract
The search for mutations in genes coding for components of the biopterin pathway other than GTPCH1 revealed a mutation in the gene coding for sepiapterin reductase (SPR) in 1 of 95 patients with GCH1-negative dopa-responsive dystonia (DRD). The mutation detected in SPR is a G-->A transition at position -13 of the untranslated region of the gene. This resulted in drastically reduced activity of sepiapterin reductase in the patient's fibroblasts. The findings indicate that haploinsufficiency of SPR can be a rare cause of DRD.
AuthorsDaniela Steinberger, Nenad Blau, Dimitri Goriuonov, Juliane Bitsch, Michael Zuker, Sibylla Hummel, Ulrich Müller
JournalNeurogenetics (Neurogenetics) Vol. 5 Issue 3 Pg. 187-90 (Sep 2004) ISSN: 1364-6745 [Print] United States
PMID15241655 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 5' Untranslated Regions
  • Alcohol Oxidoreductases
  • sepiapterin reductase
Topics
  • 5' Untranslated Regions
  • Adult
  • Alcohol Oxidoreductases (genetics)
  • Blotting, Western
  • DNA Mutational Analysis
  • Dystonic Disorders (genetics)
  • Exons
  • Female
  • Fibroblasts (metabolism)
  • Heterozygote
  • Humans
  • Models, Biological
  • Mutation
  • Polymerase Chain Reaction
  • Skin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: